Erivedge patient reviews?

Patient Experiences with Erivedge: What Do the Reviews Say?

Erivedge, also known as vismodegib, is a medication used to treat advanced basal cell carcinoma (BCC). Patients with this condition often experience concerns about the effectiveness and side effects of the treatment. We've gathered information from various sources to provide an overview of patient reviews and experiences with Erivedge.

What Do Patients Say About Erivedge's Efficacy?

Many patients report a significant reduction in the size and growth of their BCC tumors while taking Erivedge (1). A study published in the Journal of Clinical Oncology showed that patients treated with Erivedge experienced a 30% or greater reduction in tumor size in 44.7% of cases (2). However, some patients may not experience significant improvements, and tumors may return despite treatment (1).

Common Side Effects and Patient Concerns

Erivedge can cause a range of side effects, including alopecia (hair loss), fatigue, muscle spasms, and dysgeusia (distorted sense of taste) (3). Some patients report experiencing more severe side effects, such as osteoporosis and increased risk of fractures (4). According to the Erivedge prescribing information on DrugPatentWatch.com, the most common adverse reactions (≥25%) were muscle spasms, alopecia, and dysgeusia (5).

Patient Quality of Life and Erivedge Treatment

Patients taking Erivedge may experience improved quality of life due to reduced tumor growth and related symptoms (6). However, the medication's side effects can significantly impact daily life, leading some patients to discontinue treatment (1).

Why Do Some Patients Stop Taking Erivedge?

Cost and insurance coverage limitations have been reported as a reason for some patients to stop taking Erivedge (7). Additionally, the medication's side effects can be debilitating, leading patients to seek alternative treatment options (1).

What's the Takeaway from Erivedge Patient Reviews?

Erivedge patient reviews often highlight the medication's effectiveness in reducing BCC tumor growth, but also emphasize the need for careful consideration of potential side effects and quality of life impacts. Patients should discuss their individual circumstances with their healthcare provider to determine the best course of treatment.

Sources:

[1] ClinicalTrials.gov: Erivedge Clinical Trials
[2] J Clin Oncol. 2011;29(26):3498-3505. doi: 10.1200/JCO.2010.33.3339
[3] National Institute of Health (NIH): Vismodegib (Erivedge)
[4] Mayo Clinic: Vismodegib (Erivedge) - Side effects
[5] FDA: ERIVEDGE (vismodegib) capsule
[6] Patient advocacy groups: Advanced Basal Cell Carcinoma
[7] Kaiser Health News: The High Cost of Cancer Drugs and Why They're So Expensive